Bio NJ: Strategic Communications in the Midst of a Crisis: Legal Considerations & Beyond

Linda Pissott Reig, shareholder and co-chair of the firm's FDA practice, participated in a Bio NJ webinar " Strategic Communications in the Midst of a Crisis: Legal Considerations & Beyond" 

When a crisis hits -– whether negative clinical trial results, sudden termination of a key contract or collaboration, a major manufacturing mishap, or a significant regulatory action -– companies need to communicate and report to their stakeholders, both to satisfy legal and contractual obligations, and to adequately inform various constituencies. Communications and other company decision-makers must work quickly to craft and execute on a communications strategy. The panel focused on key questions: When it comes to regulators, investors, your Board, lenders, insurers, collaboration partners, employees, whom do you tell, and what, how and when do you tell them?